The positive impact of cariprazine in schizophrenia treatment management – case report

Abstract

Schizophrenia, recognized as a leading cause of global disability, stands as a multifaceted challenge for mental health professionals. Despite advancements in the field, schizophrenia persists as a condition which needs ongoing research and the development of individualized approaches to enhance treatment outcomes. This case report illustrates the transformative effects of cariprazine on a patient with paranoid schizophrenia, highlighting improvements in functionality, quality of life, and treatment adherence. While current antipsychotics address positive symptoms effectively, they fall short in managing negative symptoms, creating a notable treatment gap. Cariprazine, with its unique receptor profile, emerges as a promising solution, demonstrating efficacy in improving both negative and cognitive symptoms. The importance of addressing negative symptoms introduces cariprazine as a valuable intervention and emphasizes the need for ongoing research to optimize schizophrenia treatment strategies.